We are live on ! Find out more
BGMSP

Bio Green Med Solution Inc Preferred Stock
BGMSP

Delisted

BGMSP was delisted on the 20th of March, 2026.

Back to rankings

1 hedge funds and large institutions have $0 invested in Bio Green Med Solution Inc Preferred Stock in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

0.16% less ownership

Funds ownership: 0.16% → 0% (-0.16%)

100% less capital invested

Capital invested by funds: $4K → $0 (-$4K)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
+$90

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$4K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
1
UBS Group
Switzerland
– -$4K -548 Closed
TRCT
2
Tower Research Capital (TRC)
New York
– +$90 +10 New

BGMSP Hedge Fund Activity: Q4 2022 in Review

1 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Bio Green Med Solution Inc Preferred Stock (BGMSP) for Q4 2022, worth a combined $0 — down 100% from $4K a quarter earlier.

Fund positioning in BGMSP was balanced in Q4 2022: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.

The largest buyer was Tower Research Capital (TRC), opening a new position worth an estimated $90. The largest seller was UBS Group, exiting entirely with an estimated $4K sold.

  • 1 institutional investor held Bio Green Med Solution Inc Preferred Stock (BGMSP) as of Q4 2022, unchanged from Q3 2022.
  • Funds reported $0 of Bio Green Med Solution Inc Preferred Stock stock for Q4 2022, down 100% quarter-over-quarter.
  • 1 fund opened new Bio Green Med Solution Inc Preferred Stock positions in Q4 2022 and 1 closed out, a net change of 0 holders.
  • The largest Bio Green Med Solution Inc Preferred Stock buyer in Q4 2022 was Tower Research Capital (TRC), an estimated $90 added.
  • The largest Bio Green Med Solution Inc Preferred Stock seller in Q4 2022 was UBS Group, an estimated $4K sold.

Based on aggregated 13F filings for Q4 2022.